Targeting osteoclast-osteoblast communication

Nature Medicine

Volumn 17, Issue 11, 2011, Pages 1344-1346

  Cao, Xu ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; PLEXIN; PLEXIN B1; SEMAPHORIN; SEMAPHORIN 4D; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

BONE DISEASE; BONE MATRIX; CELL COMMUNICATION; CELL DIFFERENTIATION; DRUG TARGETING; GENE DELETION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY;

ANIMALS; ANTIGENS, CD; FEMALE; HUMANS; OSTEOCLASTS; OSTEOGENESIS; SEMAPHORINS;

EID: 81255211982     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2499     Document Type: Short Survey

References (12)

1. Teitelbaum, S.L. Science 289, 1504-1508 (2000).
2. Zaidi, M. Nat. Med. 13, 791-801 (2007).
3. Johnell, O. et al. Osteoporos. Int. 17, 1726-1733 (2006).
4. Matthew, T. et al. Mayo Clin. Proc. 83, 1032-1045 (2008).
5. Reid, I.R. Bone 44, 4-10 (2009).
6. Negishi-Koga, T. et al. Nat. Med. 17, 1473-1480 (2011)
7. Tang, Y. et al. Nat. Med. 15, 757-765 (2009).
8. Wu, X. et al. Cell Stem Cell 7, 571-580 (2010).
9. Suda, T. et al. Endocr. Rev. 20, 345-357 (1999).
10. Lee, J. et al. J. Biol. Chem. 285, 26618-26627 (2010).
11. McBeath, R. et al. Dev. Cell 6, 483-495 (2004).
12. Kumanogoh, A. et al. Immunity 13, 621-631 (2000).